A persistent virus vector confers superior anti-tumor immunity, compared with a non-persistent vector.

Cancer Immunology, Immunotherapy : CII
Weijun ZhangEdward J Usherwood

Abstract

Active vaccination strategies using viral vectors often give disappointing protection from tumor development, and usually require multiple immunizations. These approaches normally use viruses that cause acute infections, as they provoke potent CD8 T cell responses. Persistent virus vectors have not been used in this setting due to the perception that exhaustion of the T cell response occurs and would lead to poor anti-tumor protection. However, such exhaustion generally only occurs in high-load virus infections, whereas T cell function is intact in lower-load persistent infections. In fact, CD8 T cell responses in these infections, which are adapted for long-term immune surveillance, have properties that may make them more desirable for long-term anti-tumor immunity. In this report, we show that a persistent gammaherpesvirus vector provides superior protection against melanoma, relative to a non-persistent mutant of the same virus. These data suggest that vaccine vectors derived from persistent viruses may perform better than those from acute viruses at mediating anti-tumor protection.

References

Sep 1, 1992·The Journal of General Virology·N P Sunil-ChandraA A Nash
Apr 1, 1996·The Journal of General Virology·E J UsherwoodA A Nash
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·P G StevensonP C Doherty
Dec 3, 2003·The Journal of General Virology·Polly FowlerStacey Efstathiou
Jan 7, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Joshua J ObarEdward J Usherwood
Mar 3, 2004·The Journal of General Virology·Polly Fowler, Stacey Efstathiou
May 14, 2004·Journal of Virology·E John Wherry, Rafi Ahmed
May 14, 2005·Blood·Tong ZhangCharles L Sentman
Dec 13, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Caroline L SmithVincenzo Cerundolo
Jan 17, 2008·Critical Reviews in Immunology·Philip M ArlenJeffrey Schlom
Jun 11, 2008·Critical Reviews in Immunology·Shinichiro FuseEdward J Usherwood

❮ Previous
Next ❯

Citations

Jan 12, 2011·Annual Review of Immunology·Erik BartonSamuel H Speck
Dec 5, 2020·Seminars in Immunology·Jichang HanChristina V Angeles

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.